- Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
-
Kamimura M, Nakamura Y, Ikegami S, Komatsu M, Uchiyama S, Kato H
- KMID: 2368635
- Osteoporos Sarcopenia.
- 2016 Sep;2(3):170-174.
- doi: 10.1016/j.afos.2016.07.002
As a bisphosphonate, minodronate (MIN) is one of the strongest inhibitors of bone resorption. However, there have been no reports directly comparing the antiresorptive effects of monthly MIN with those... -
- CITED
-
- Close
- SHARE
-
- Close
- Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
-
Suzuki T, Nakamura Y, Kamimura M, Ikegami S, Uchiyama S, Kato H
- KMID: 2387467
- Osteoporos Sarcopenia.
- 2017 Jun;3(2):108-111.
- doi: 10.1016/j.afos.2017.03.003
OBJECTIVES: The aim of this study was to examine the discontinuation and occurrence of fracture during denosumab treatment in Japanese women with primary osteoporosis or rheumatoid arthritis (RA) with osteoporosis. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
